Group Says Roche Holding AG’s Diet Drug Linked To Pre-Cancer; Seeks Ban

Roche Holding AG’s prescription diet drug Xenical should immediately be pulled from the U.S. market after recent data linked it to precancerous colon lesions in animal studies, a consumer group told federal health regulators on Monday.

MORE ON THIS TOPIC